|
1
|
Cheikh N, Villemin D, Bar N, Lohier JF, Choukchou-Braham N, Mostefa-Kara B, Sopkova J. A serendipitous conversion of enaminolactone nitriles with primary amines: a new synthesis of substituted 2-aminopyridine derivatives. Tetrahedron 2013. [DOI: 10.1016/j.tet.2012.10.108] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
|
2
|
Reuman M, Beish S, Davis J, Batchelor MJ, Hutchings MC, Moffat DFC, Connolly PJ, Russell RK. Scalable Synthesis of the VEGF-R2 Kinase Inhibitor JNJ-17029259 Using Ultrasound-Mediated Addition of MeLi−CeCl3 to a Nitrile. J Org Chem 2008; 73:1121-3. [DOI: 10.1021/jo7021372] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael Reuman
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - Sandra Beish
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - Jeremy Davis
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - Mark J. Batchelor
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - Martin C. Hutchings
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - David F. C. Moffat
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - Peter J. Connolly
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| | - Ronald K. Russell
- Johnson and Johnson Pharmaceutical Research & Development, L.L.C., 1000 Route 202, Raritan, New Jersey 08869, and UCB Pharma, 216 Bath Road, Slough, SL14EN, United Kingdom
| |
Collapse
|
|
4
|
Esteve-Romero JS, Pons LM, García-Alvarez-Coque MC, Ramis-Ramos G. Determination of Pyrrole Derivatives and Hydroxyproline with 4-(Dimethylamino)benzaldehyde in a Micellar Medium. ANAL LETT 1994. [DOI: 10.1080/00032719408006389] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
|
6
|
Takahashi M, Mamiya T, Hasegawa H, Nagai T, Wakita H. Preparation of 1,5-disubstituted 4-sulfonylpyrazoles, β-cyano-β-sulfonylenamines and 5-substituted 4-sulfonylisoxazoles from β-keto-β-sulfonylenamines. J Heterocycl Chem 1986. [DOI: 10.1002/jhet.5570230520] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
|
8
|
Kantlehner W, Haug E, Hagen H. Orthoamide, XXXVI1) Zur Formylierung von 2,5-Dialkyl-1,3,4-thiadiazolen und 2,3,5-Trialkyl-1,3,4-thiadiazoliumsalzen durch Orthoamide der Ameisensäure. European J Org Chem 1982. [DOI: 10.1002/jlac.198219820213] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|